GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Amplifon SpA (GREY:AMFPF) » Definitions » Research & Development

Amplifon SpA (Amplifon SpA) Research & Development : $0 Mil (TTM As of Dec. 2023)


View and export this data going back to . Start your Free Trial

What is Amplifon SpA Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Amplifon SpA's Research & Development for the three months ended in Dec. 2023 was $0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 was $0 Mil.

Amplifon SpA Research & Development Historical Data

The historical data trend for Amplifon SpA's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Amplifon SpA Research & Development Chart

Amplifon SpA Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Amplifon SpA Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Amplifon SpA Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Amplifon SpA  (GREY:AMFPF) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Amplifon SpA Research & Development Related Terms

Thank you for viewing the detailed overview of Amplifon SpA's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Amplifon SpA (Amplifon SpA) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Amplifon SpA (GREY:AMFPF) » Definitions » Research & Development
Comparable Companies
MIL:FCH MIL:INT MIL:OLI MIL:CFV MIL:DHH MIL:OS MIL:ABTG MIL:KK MIL:PLN MIL:SMN MCK COR CAH HSIC SHSE:601607 HKSE:01099 NZSE:EBO XSWX:GALE SHSE:600511 TSE:7459
Traded in Other Exchanges
AMP:Italy AMPm:UK 0N61:UK AXNA:Germany
Address
Via Ripamonti, 133, Milano, ITA, 20141
Website
https://corporate.amplifon.com
Amplifon SpA provides customizable hearing solutions and services through a distribution network of network affiliates, corporate shops, franchises, and shop-in-shops. Amplifon operates in three segments based on geography: the Americas; Europe, the Middle East, and Africa; and Asia-Pacific. It generates the majority of its revenue in the EMEA region. Amplifon operates under a variety of brands in these regions, including Amplifon, Beter Horen, Maxtone, and Miracle-Ear. The majority of Amplifon's direct points of sale are in Italy.